Is CAFRX or JNJ a better dividend investment in 2026?

CAFRX currently yields 4.00% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CAFRX offers higher current income.

What is the dividend yield difference between CAFRX and JNJ?

CAFRX has a forward dividend yield of 4.00% ($0.45/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 0.64 percentage points.

Home › Compare › CAFRX vs JNJ

CAFRX vs JNJ: Dividend Comparison 2026

CAFRX yields 4.00% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CAFRX wins by $5.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CAFRX

● Live price

4.00%

Share price

$11.36

Annual div

$0.45

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$516.54

Full CAFRX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CAFRX vs JNJ

📍 CAFRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CAFRX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CAFRX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CAFRX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAFRX

Annual income on $10K today (after 15% tax)

$339.70/yr

After 10yr DRIP, annual income (after tax)

$439.06/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $264.55/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAFRX + JNJ for your $10,000?

CAFRX: 50%JNJ: 50%

100% JNJ50/50100% CAFRX

Portfolio after 10yr

$23.0K

Annual income

$672.16/yr

Blended yield

2.92%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CAFRX

No analyst data

Altman Z

-0.5

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAFRX buys

JNJ buys

No recent congressional trades found for CAFRX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCAFRXJNJ

Forward yield	4.00% ✓	3.36%
Annual dividend / share	$0.45	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$25.9K ✓	$20.0K
Annual income after 10y	$516.54	$827.78 ✓
Total dividends collected	$4.6K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CAFRX vs JNJ ($10,000, DRIP)

Year	CAFRX Portfolio	CAFRX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,100	$399.65	$10,676	$355.77	+$424.00 → CAFRX
2	$12,291	$414.57	$11,407	$389.39	+$884.00 → CAFRX
3	$13,581	$429.05	$12,198	$426.53	+$1.4K → CAFRX
4	$14,974	$443.04	$13,056	$467.62	+$1.9K → CAFRX
5	$16,479	$456.55	$13,987	$513.12	+$2.5K → CAFRX
6	$18,102	$469.56	$14,998	$563.56	+$3.1K → CAFRX
7	$19,851	$482.06	$16,098	$619.52	+$3.8K → CAFRX
8	$21,735	$494.06	$17,295	$681.69	+$4.4K → CAFRX
9	$23,762	$505.55	$18,599	$750.82	+$5.2K → CAFRX
10	$25,942	$516.54	$20,022	$827.78	+$5.9K → CAFRX

CAFRX vs JNJ: Complete Analysis 2026

CAFRX — Stock

Under normal market conditions, the fund invests at least 80% of its net assets in the securities of, and depositary receipts (including American Depositary Receipts ("ADRs"), Global Depositary Receipts ("GDRs"), and European Depositary Receipts ("EDRs")) represented by, African issuers that are tied economically to Africa. It may also enter into derivative transactions.

Full CAFRX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CAFRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAFRX vs SCHD CAFRX vs JEPI CAFRX vs O CAFRX vs KO CAFRX vs MAIN CAFRX vs ABBV CAFRX vs MRK CAFRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.